Intestinal spirochetosis: an unusual cause of IBD flare-up during anti-TNF therapy

被引：1
|
作者：
Fonseca Chebli, Julio Maria [1 ,2 ,3 ]
de Abreu, Nathalia Chebli [1 ]
Chebli, Liliana Andrade [1 ,2 ]
Reboredo, Maycon Moura [2 ]
Pinheiro, Helady Sanders [2 ]
机构：
[1] Univ Fed Juiz de Fora, Univ Hosp, Div Gastroenterol, Ctr Inflammatory Bowel Dis, Av Eugenio Nascimento S-N, BR-36038330 Juiz De Fora, MG, Brazil
[2] Univ Fed Juiz de Fora, Sch Med, Dept Med, Av Eugenio Nascimento S-N, BR-36038330 Juiz De Fora, MG, Brazil
[3] Rua Maria Jose Leal 296, BR-36036247 Juiz De Fora, MG, Brazil
来源：
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE | 2016年 / 31卷 / 03期
关键词：
Infliximab; Fecal Calprotectin; Disease Flare; Colorectal Epithelial Cell; Gastroenterology Outpatient Clinic;
D O I：
10.1007/s00384-015-2240-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [1] Intestinal spirochetosis: an unusual cause of IBD flare-up during anti-TNF therapy
    Julio Maria Fonseca Chebli
    Nathália Chebli de Abreu
    Liliana Andrade Chebli
    Maycon Moura Reboredo
    Helady Sanders Pinheiro
    International Journal of Colorectal Disease, 2016, 31 : 745 - 746
  • [2] Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak
    Rimondi, Alessandro
    Tontini, Gian Eugenio
    Mazza, Stefano
    Caprioli, Flavio
    Sangiovanni, Angelo
    Lampertico, Pietro
    Vecchi, Maurizio
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (10) : E128 - E129
  • [3] Anti-TNF Agents in Elderly IBD Patients: Cause for Concern?
    Lowenberg, Mark
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 881 - 882
  • [4] IBD Antibodies to anti-TNF therapy-consequences for IBD management
    van Deen, Welmoed K.
    Hommes, Daniel W.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (08) : 446 - 448
  • [5] Antibodies to anti-TNF therapy—consequences for IBD management
    Welmoed K. van Deen
    Daniel W. Hommes
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 446 - 448
  • [6] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [7] Understanding the Cause of Weight Gain in Patients With IBD on Anti-TNF Medications
    Winter, Rachel W.
    Friedman, Sonia
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : 132 - 133
  • [8] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Kumar, Manoj
    Murugesan, Selvasankar
    Ibrahim, Nazira
    Elawad, Mamoun
    Al Khodor, Souhaila
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [9] MOOD AND ANXIETY DISORDERS AND PERSISTANCE WITH ANTI-TNF THERAPY IN IBD
    Targownik, Laura E.
    Dolovich, Casandra
    Tennakoon, Aruni
    Nugent, Zoann
    Bolton, James
    Sareen, Jitender
    Marrie, Ruth Ann
    Singh, Harminder
    Bernstein, Charles N.
    GASTROENTEROLOGY, 2019, 156 (06) : S880 - S880
  • [10] Liver Injury Associated with Anti-TNF Therapy in Pediatric IBD
    Ricciuto, Amanda
    Kamath, Binita
    Walters, Thomas D.
    Church, Peter
    Ling, Simon
    Frost, Karen
    Griffiths, Anne M.
    GASTROENTEROLOGY, 2016, 150 (04) : S927 - S927
12345